<h4>Introduction</h4>Sclerostin, a negative regulator of bone formation, has been involved in memory impairment in Alzheimer's disease (AD) mouse models and is increased in elderly people at risk of AD. Here, SOST is linked to early-onset autosomal dominant Alzheimer disease.